Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation

Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study, JAMA, 285, 2370, 10.1001/jama.285.18.2370 Go, 2014, Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, e28, 10.1161/01.cir.0000441139.02102.80 Kim, 2011, Estimation of total incremental health care costs in patients with atrial fibrillation in the United States, Circ Cardiovasc Qual Outcomes, 4, 313, 10.1161/CIRCOUTCOMES.110.958165 Piccini, 2012, Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993–2007, Circ Cardiovasc Qual Outcomes, 5, 85, 10.1161/CIRCOUTCOMES.111.962688 Miyasaka, 2006, Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades, Eur Heart J, 27, 936, 10.1093/eurheartj/ehi694 Santhanakrishnan, 2016, Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction, Circulation, 133, 484, 10.1161/CIRCULATIONAHA.116.022835 Schnabel, 2013, Risk assessment for incident heart failure in individuals with atrial fibrillation, Eur J Heart Fail, 15, 843, 10.1093/eurjhf/hft041 Wang, 2003, Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study, Circulation, 107, 2920, 10.1161/01.CIR.0000072767.89944.6E Thihalolipavan, 2015, Atrial fibrillation and heart failure: update 2015, Prog Cardiovasc Dis, 58, 126, 10.1016/j.pcad.2015.07.004 Potpara, 2013, Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study, Eur J Heart Fail, 15, 415, 10.1093/eurjhf/hft004 Piccini, 2011, Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF, Am Heart J, 162, 606, 10.1016/j.ahj.2011.07.001 Holmqvist, 2015, Heart rate is associated with progression of atrial fibrillation, independent of rhythm, Heart, 101, 894, 10.1136/heartjnl-2014-307043 Steinberg, 2015, Increased heart rate is associated with higher mortality in patients with atrial fibrillation (AF): results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF), J Am Heart Assoc, 4, e002031, 10.1161/JAHA.115.002031 Holmqvist, 2015, Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF), Am Heart J, 169, 647, 10.1016/j.ahj.2014.12.024 Avery, 2012, The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study, J Am Coll Cardiol, 60, 1640, 10.1016/j.jacc.2012.07.022 Gerber, 2015, A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010, JAMA Intern Med, 175, 996, 10.1001/jamainternmed.2015.0924 Suzuki, 2012, A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation, Am J Cardiol, 110, 678, 10.1016/j.amjcard.2012.04.049 Kannel, 1998, Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates, Am J Cardiol, 82, 2N, 10.1016/S0002-9149(98)00583-9 Zile, 2011, Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction, Circulation, 124, 2491, 10.1161/CIRCULATIONAHA.110.011031 Everett, 2007, Atrial fibrosis and the mechanisms of atrial fibrillation, Heart Rhythm, 4, S24, 10.1016/j.hrthm.2006.12.040 Tsang, 2002, Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women, J Am Coll Cardiol, 40, 1636, 10.1016/S0735-1097(02)02373-2 Miller, 2015, Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation, J Am Coll Cardiol, 66, 2899, 10.1016/j.jacc.2015.10.047 Menezes, 2013, Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies, Mayo Clin Proc, 88, 394, 10.1016/j.mayocp.2013.01.022 De Vos, 2012, Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy, Am Heart J, 163, 887, 10.1016/j.ahj.2012.02.015 Boriani, 2016, 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry, Europace, 18, 648, 10.1093/europace/euv390 Camm, 2012, 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the Management of Atrial Fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, 33, 2719, 10.1093/eurheartj/ehs253 Van Gelder, 2010, Lenient versus strict rate control in patients with atrial fibrillation, N Engl J Med, 362, 1363, 10.1056/NEJMoa1001337 Andersen, 2014, Heart failure with preserved ejection fraction: current understandings and challenges, Curr Cardiol Rep, 16, 501, 10.1007/s11886-014-0501-8 Khazanie, 2014, Outcomes of Medicare beneficiaries with heart failure and atrial fibrillation, J Am Coll Cardiol HF, 2, 41 Gupta, 2013, Heart failure with preserved ejection fraction in African Americans: the ARIC (Atherosclerosis Risk In Communities) study, J Am Coll Cardiol HF, 1, 156 Seliger, 2015, Older adults, “malignant” left ventricular hypertrophy, and associated cardiac-specific biomarker phenotypes to identify the differential risk of new-onset reduced versus preserved ejection fraction heart failure: CHS (Cardiovascular Health Study), J Am Coll Cardiol HF, 3, 445